Literature DB >> 30118622

Marijuana and Prescription Pain Reliever Use among Cigarette Smokers.

Rachel L Goldberg1,2,3, Janine K Cataldo1,2,3.   

Abstract

Due to marijuana's analgesic effects and its growing national legal status, it is likely that marijuana's rising prevalence will impact prescription pain reliever (PPR) use. The present study investigates the relationship between marijuana and PPR use among U.S. adult current cigarette smokers. Data were analyzed from the Tobacco and Attitudes Beliefs Survey II, with 348 current cigarette smokers, aged 24-88. Logistic regression was used to examine the likelihood of current (past 30 days) PPR use by marijuana use (never, ever, and current) among cigarette smokers. Among PPR users (N = 76), we also investigated whether marijuana use frequency predicted current PPR use. Compared to never marijuana users, participants were more likely to report past 30-day PPR use if they have ever used marijuana (AOR: 2.58, 95% CI: 1.51-4.43) or have used marijuana in the past 30 days (AOR: 3.38, CI: 1.76-6.49). No significant relationship was found between marijuana use frequency and PPR use. Thus, in this sample of adult cigarette smokers, past and current marijuana users were two to three times more likely to report PPR use than never marijuana users. These findings can help inform policymakers and healthcare providers in their fight against the opioid epidemic.

Entities:  

Keywords:  Cigarettes; dual-use; marijuana; prescription pain relievers; substance use; tobacco

Mesh:

Substances:

Year:  2018        PMID: 30118622      PMCID: PMC6245941          DOI: 10.1080/02791072.2018.1506598

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  39 in total

1.  Nicotinic and opioid receptor interactions in nicotine addiction.

Authors:  Daniel S McGehee
Journal:  Mol Interv       Date:  2006-12

Review 2.  Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.

Authors:  Fernando Berrendero; Patricia Robledo; José Manuel Trigo; Elena Martín-García; Rafael Maldonado
Journal:  Neurosci Biobehav Rev       Date:  2010-02-16       Impact factor: 8.989

Review 3.  Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Authors:  Mary E Lynch; Fiona Campbell
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

4.  Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details.

Authors:  Rosalie L Pacula; David Powell; Paul Heaton; Eric L Sevigny
Journal:  J Policy Anal Manage       Date:  2015

Review 5.  Nicotine and endogenous opioids: neurochemical and pharmacological evidence.

Authors:  Maria Hadjiconstantinou; Norton H Neff
Journal:  Neuropharmacology       Date:  2010-11-22       Impact factor: 5.250

6.  Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence.

Authors:  Magdalena Cerdá; Melanie Wall; Katherine M Keyes; Sandro Galea; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2011-11-17       Impact factor: 4.492

7.  Nonmedical prescription pain reliever and alcohol consumption among cannabis users.

Authors:  Scott P Novak; Nicholas C Peiper; Gary A Zarkin
Journal:  Drug Alcohol Depend       Date:  2015-12-17       Impact factor: 4.492

8.  Medical Marijuana Legalization and Co-use in Adult Cigarette Smokers.

Authors:  Julie B Wang; Janine K Cataldo
Journal:  Am J Health Behav       Date:  2016-03

Review 9.  Nicotine effects and the endogenous opioid system.

Authors:  Shiroh Kishioka; Norikazu Kiguchi; Yuka Kobayashi; Fumihiro Saika
Journal:  J Pharmacol Sci       Date:  2014-05-31       Impact factor: 3.337

10.  Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain.

Authors:  Kevin F Boehnke; Evangelos Litinas; Daniel J Clauw
Journal:  J Pain       Date:  2016-03-19       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.